REGISTERED NUMBER: 11040909 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

CLINIC FACE LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

J N Blythe

REGISTERED OFFICE:

Willow Farm, Cote

Bampton

Oxfordshire

OX18 2EG

REGISTERED NUMBER:

11040909 (England and Wales)

ACCOUNTANTS:

Richmond Gatehouse LLP

Thames House, 2nd floor

3 Wellington Street

London

SE18 6NY

FIXED ASSETS

Tangible assets

4

41,033

41,451

CURRENT ASSETS

Cash at bank and in hand

16,031

35,450

CREDITORS

Amounts falling due within one year

5

(12,834

)

(37,953

)

NET CURRENT ASSETS/(LIABILITIES)

3,197

(2,503

)

TOTAL ASSETS LESS CURRENT LIABILITIES

44,230

38,948

CAPITAL AND RESERVES

Called up share capital

6

100

100

Retained earnings

7

44,130

38,848

SHAREHOLDERS' FUNDS

44,230

38,948

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 September 2025 and were signed by:

J N Blythe - Director

1.	STATUTORY INFORMATION

Clinic Face Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4.	TANGIBLE FIXED ASSETS

Fixtures

Plant and

and

Motor

Computer

machinery

fittings

vehicles

equipment

Totals

£

£

£

£

£

COST

At 1 January 2024

58,561

13,046

40,139

3,012

114,758

Additions

-

-

26,000

-

26,000

At 31 December 2024

58,561

13,046

66,139

3,012

140,758

DEPRECIATION

At 1 January 2024

32,676

10,564

28,140

1,927

73,307

Charge for year

12,943

2,482

10,500

493

26,418

At 31 December 2024

45,619

13,046

38,640

2,420

99,725

NET BOOK VALUE

At 31 December 2024

12,942

-

27,499

592

41,033

At 31 December 2023

25,885

2,482

11,999

1,085

41,451

5.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade creditors

914

914

Tax

10,372

18,565

Hire Purchase Loan (CL)

-

17,106

Directors' current accounts

52

95

Accrued expenses

1,496

1,273

12,834

37,953

6.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2024

2023

value:

£

£

100

Ordinary Share

£1

100

100

7.

RESERVES

Retained

earnings

£

At 1 January 2024

38,848

Profit for the year

38,873

Dividends

(33,591

)

At 31 December 2024

44,130